This topic contains a solution. Click here to go to the answer

Author Question: The situation least likely to lead to overindulgence in an unwanted consummatory behavior is: a. ... (Read 18 times)

jparksx

  • Hero Member
  • *****
  • Posts: 570
The situation least likely to lead to overindulgence in an unwanted consummatory behavior is:
 
  a. when you are stressed.
  b. when you are calm.
  c. when you are depressed.
  d. when you are unusually happy.

Question 2

A smoker who stays away from other smokers is:
 
  a. escaping the problem.
  b. failing to test her/his commitment.
  c. extinguishing reactions to the antecedents.
  d. avoiding antecedents to a problem behavior.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ririgirl15

  • Sr. Member
  • ****
  • Posts: 385
Answer to Question 1

B.

Answer to Question 2

D.




jparksx

  • Member
  • Posts: 570
Reply 2 on: Jun 21, 2018
YES! Correct, THANKS for helping me on my review


Liddy

  • Member
  • Posts: 342
Reply 3 on: Yesterday
Excellent

 

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library